Table 1.

Baseline patient characteristics and treatment

		Patients (N = 208)	n
Age (y/o)	Median 69 (48–90)
	Age ≤ 60	12.5%	26
	60 < Age ≤ 70	46.2%	96
	Age > 70	41.3%	86
Race	White	54.8%	114
	Black	38.0%	79
	Other	7.2%	15
Charlson Comorbidity Index	CCI = 0	68.3%	142
	CCI = 1	22.6%	47
	CCI ≥ 2	9.1%	19
Body Mass Index (BMI)	Median 27.34 (15.02-44.96)
	BMI ≥ 30	29.3%	61
Partner Status	Married or Partnered	76.4%	159
	Not Partnered	23.6%	49
Employment Status	Working	47.6%	99
	Not Working	52.4%	109
Median Prostate Volume (cc)	Median 38.6 (11.6-138.7) cc		208
Baseline AUA Score	Median 7 (0 – 34)		141
Procedure for BPH		11.5%	24
α 1A inhibitor usage		27.4%	57
Anticoagulant usage		32.2%	67
Risk Groups (D’Amico’s)	Low	39.4%	82
	Intermediate	52.4%	109
	High	8.2%	17
ADT		14.4%	30
SBRT Dose	36.25 Gy	87.5%	182
	35 Gy	12.5%	26